Q2 revenue growth of 15% year-over-year Q2 net income of $32.2 million and non-GAAP net income of $65.7 million Q2 net income margin of 12%; adjusted EBITDA margin ...

Transformative acquisition projected to generate up to an additional $7 million in annualized revenue in 2025 and further expand bottom line.Brings HACCP, GMP-certified, and FDA-registered manufacturi ...

A new platform designed by Meditrax allows real-time connection of RMMRs to My Health Record, boosting continuity of care ...

Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts.

The Territory’s ambulance service contract will be up for grabs for the first time in over half a century after St Johns was banned from performing two ‘life saving’ high risk procedures.

Lack of clinical governance: St John NT suspends use of ‘High Acuity, Low Occurrence’ procedures ‘You don’t let people fly a plane without the right training’: The Territory’s ...

Letters to the Editor, June 10th: On clinical governance, alcohol tax and gardening leave Revelations about unnecessary hip surgeries are just one part of a far wider institutional collapse Expand ...

Lack of clinical governance: St John NT suspends use of ‘High Acuity, Low Occurrence’ procedures ‘You don’t let people fly a plane without the right training’: The Territory’s ...

Paramedics have been barred from performing two ‘life saving’ but high risk procedures in the Territory due to a lack of oversight in the critical front line health service.

Chart Industries & Flowserve merger creates a $19B leader with $300M synergies, strong growth, and value-packed investment opportunities. See more on GTLS here.

Flowserve Corporation and Chart Industries, Inc. merge for $300M synergies, sparking investor skepticism on growth and strategy. Click for my take on FLS and GTLS.